Palisade Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Sell |
5,086,903
-200,028
| -4% | -$414K | 0.3% | 104 |
|
|
2025
Q1 | $11.6M | Buy |
5,286,931
+1,360,542
| +35% | +$2.99M | 0.33% | 99 |
|
|
2024
Q4 | $6.01M | Sell |
3,926,389
-65,889
| -2% | -$101K | 0.16% | 154 |
|
|
2024
Q3 | $7.94M | Sell |
3,992,278
-56,850
| -1% | -$113K | 0.21% | 127 |
|
|
2024
Q2 | $14.2M | Buy |
4,049,128
+316,887
| +8% | +$1.11M | 0.39% | 87 |
|
|
2024
Q1 | $10.3M | Buy |
3,732,241
+86,138
| +2% | +$239K | 0.27% | 109 |
|
|
2023
Q4 | $6.2M | Sell |
3,646,103
-464,848
| -11% | -$790K | 0.16% | 147 |
|
|
2023
Q3 | $4.23M | Sell |
4,110,951
-32,698
| -0.8% | -$33.7K | 0.12% | 170 |
|
|
2023
Q2 | $4.81M | Buy |
4,143,649
+173,363
| +4% | +$201K | 0.13% | 165 |
|
|
2023
Q1 | $6M | Buy |
3,970,286
+184,391
| +5% | +$278K | 0.16% | 153 |
|
|
2022
Q4 | $9.46M | Buy |
3,785,895
+397,263
| +12% | +$993K | 0.25% | 120 |
|
|
2022
Q3 | $14.3M | Buy |
3,388,632
+424,558
| +14% | +$1.79M | 0.41% | 82 |
|
|
2022
Q2 | $8.27M | Buy |
2,964,074
+42,967
| +1% | +$120K | 0.22% | 130 |
|
|
2022
Q1 | $16.7M | Sell |
2,921,107
-113,065
| -4% | -$647K | 0.38% | 91 |
|
|
2021
Q4 | $27.7M | Buy |
3,034,172
+542,589
| +22% | +$4.95M | 0.56% | 60 |
|
|
2021
Q3 | $26.6M | Buy |
2,491,583
+672,452
| +37% | +$7.19M | 0.58% | 55 |
|
|
2021
Q2 | $28.2M | Buy |
1,819,131
+755,397
| +71% | +$11.7M | 0.64% | 53 |
|
|
2021
Q1 | $17.2M | Buy |
1,063,734
+173,116
| +19% | +$2.81M | 0.41% | 91 |
|
|
2020
Q4 | $18.9M | Buy |
890,618
+70,079
| +9% | +$1.48M | 0.48% | 72 |
|
|
2020
Q3 | $12.2M | Buy |
820,539
+145,174
| +21% | +$2.15M | 0.36% | 98 |
|
|
2020
Q2 | $9.94M | Buy |
675,365
+5,127
| +0.8% | +$75.4K | 0.32% | 108 |
|
|
2020
Q1 | $7.87M | Buy |
670,238
+75,040
| +13% | +$881K | 0.28% | 119 |
|
|
2019
Q4 | $14M | Buy |
595,198
+54,379
| +10% | +$1.28M | 0.4% | 88 |
|
|
2019
Q3 | $10M | Buy |
540,819
+33,398
| +7% | +$618K | 0.31% | 105 |
|
|
2019
Q2 | $9.43M | Buy |
507,421
+122,680
| +32% | +$2.28M | 0.29% | 110 |
|
|
2019
Q1 | $9.4M | Buy |
384,741
+81,135
| +27% | +$1.98M | 0.3% | 107 |
|
|
2018
Q4 | $7.88M | Buy |
+303,606
| New | +$7.88M | 0.29% | 122 |
|